2026 ISPE Europe Annual Conference

Thank you to all who made the 2026 ISPE Europe Annual Conference such a big success!

Thank you to all who made the 2026 ISPE Europe Annual Conference such a big success!

Please Note:

  • All full-access registration (virtual & in-person) includes access to speaker presentations, on-demand content, and other conference material.
  • NOTE: Material is only available from those speakers/companies that permitted distribution.
  • Registrants will receive email notification when the on-demand content is available.
  • On-demand content is accessible for 90 days.

Access Conference Platform

End Users and Thought Leaders Who Participated in the 2026 ISPE Europe Annual Conference

Conference Overview

20 - 22 Apr 2026 Copenhagen, Denmark and Virtual

 

The 2026 ISPE Europe Annual Conference brings together pharmaceutical and biopharmaceutical professionals from all levels of the industry – from students and emerging leaders to the most senior executives in drug manufacturing, supply chain, devices, equipment, and services, and global regulatory agencies.

This flagship event will explore how cutting-edge technologies, such as artificial intelligence and machine learning (AI/ML), virtual and augmented reality, and smart manufacturing, are reshaping our industry. We’ll also spotlight breakthroughs in biopharmaceuticals and Advanced Therapy Medicinal Products (ATMPs), and dive into practical strategies for addressing current challenges such as drug shortages and improving global access to medicines.

Participants will benefit from expert-led sessions on enhancing operational efficiency, ensuring project success, and sharing real-world case studies. Whether you’re here to discover emerging trends, contribute lessons learned, or benchmark best practices, the 2026 ISPE Europe Annual Conference offers a collaborative platform for driving innovation and excellence.

We look forward to your contribution and to collectively shaping the future of pharmaceutical and biopharmaceutical manufacturing at this year’s conference.

Featured Speakers

Image
26 EAC - Website Thumbnail - Brendan Cuddy
Image
26 EAC - Ian Jackson

2026 ISPE Europe Annual Conference Photo Gallery

Conference Highlights

David Estapé Chair of the Conference International Program Committee

Podcast Preview: What to Look Forward to at the 2026 ISPE Europe Annual Conference

The pharmaceutical industry is undergoing one of the most intense periods of transformation in its history. Advances in science, the acceleration of digital technologies, evolving regulatory expectations, and mounting sustainability pressures are reshaping how medicines are developed and manufactured. Against this backdrop, the 2026 ISPE Europe Annual Conference promises to be a defining moment for industry professionals navigating this increasingly complex landscape.

Thomas Centner, PhD-EU26-sustainability-session

Sustainability, Quality, and Project Excellence Take Center Stage at the 2026 ISPE Europe Annual Conference

From 20–22 April 2026, the 2026 ISPE Europe Annual Conference will bring pharmaceutical and biopharmaceutical professionals to Copenhagen, Denmark, for three days of focused discussion on the challenges shaping the future of regulated manufacturing. As sustainability expectations accelerate and project delivery pressures intensify, the conference program reflects a clear priority: translating innovation into practical, good manufacturing practices (GMP) ready solutions across the facility and project lifecycle.

EU-session-operation excellence-750px

From Validation 4.0 to Embedded Data Integrity: Practical Strategies for Pharma Transformation at the 2026 ISPE Europe Annual Conference

As pharmaceutical manufacturers accelerate digital transformation, many organizations face a familiar challenge: how to adopt modern technologies without increasing compliance risk or operational friction. The 2026 ISPE Europe Annual Conference brings industry leaders together to address exactly this tension—bridging innovation, quality, and regulatory expectations with proven, real-world approaches.

International Program Committee

Board Liaison
Global Lead, Site Engineering, Synthetics
Johnson & Johnson
External Affairs Director, Audits, Inspection & Quality Intelligence
Novo Nordisk
Emerging Leader
Process Engineer MS&T Drug Substance
Takeda

Conference Sponsors & Supporters

Media Partners